Troglitazone-Associated Hepatic Failure
A Booth, Stephen Hugh Caldwell, Julia C. Iezzoni · The American Journal of Gastroenterology · 2000
University of Virginia-HSC, Departments of Pathology and Internal Medicine, Charlottesville, Virginia, USA Reprint requests and correspondence: A M Booth, University of Virginia-HSC, Department of Pathology, Box 214, Charlottesville, VA 22908. Received 11 August 1999; accepted 24 August 1999
Cited by 33 works. doi:10.1016/s0002-9270(99)00865-5
Authors
References
- Troglitazone, an insulin action enhancer, improves metabolic control in NIDDM patients
- Hepatic Dysfunction Associated with Troglitazone
- Troglitazone-Induced Hepatic Failure Leading to Liver Transplantation: A Case Report
- Two Cases of Severe Clinical and Histologic Hepatotoxicity Associated with Troglitazone
- Fatal Hepatotoxicity Associated with Troglitazone
- Troglitazone, an insulin action enhancer, improves metabolic control in NIDDM patients
- Troglitazone-Associated Hepatic Failure